| 7:30
AM |
|
Breakfast
& Registration |
Session
I: Autoimmune & Inflammatory Disorders – A Changing
Concept: Unifying Immunopathologic Mechanisms
Moderators: Leonard Calabrese & Nizar Zein |
| 8:30
AM |
|
Welcoming
Remarks
Leonard Calabrese |
| KEYNOTE
SPEAKER |
| 8:40
AM |
|
Role
of T-Cells in Inflammatory Disease States: From Autoimmunity
to Atherosclerosis
Cornelia Weyand |
| 9:40
AM |
|
Refreshment
Break |
| 10:00
AM |
|
Influence
of Shifting TH1 / TH2 Balance in Health and Disease
Iain McInnes |
| 10:40
AM |
|
B
Cells in Autoimmune Disease
Peter Lipsky |
| 11:20
AM |
|
Innate
Immunity: A Central Pathway in Inflammatory Diseases
Steven Porcelli |
| 12:00
PM |
|
Luncheon |
| Session
II: TNF as a Therapeutic Target Moderators: Claudio
Fiocchi & William Rigby |
| 1:00
PM |
|
Central
Role of TNF in Multiple Inflammatory Disease States
David Fox |
| 1:40
PM |
|
Current
and Future Agents: Structure, Pharmacology, (Pk-PD), Activity
& Indications
Leonard Calabrese |
| 2:20
PM |
|
TNF
and Inflammatory Cytokines in the Pathogenesis of Inflammatory
Bowel Disease
Claudio Fiocchi |
| 3:00
PM |
|
Refreshment
Break |
| 3:20
PM |
|
TNF
and Inflammatory Cytokines in the Pathogenesis of Sarcoidosis
and Interstitial Lung Disease
Mary Jane Thomassen |
| 4:00
PM |
|
Differences
in Efficacy in Granulomatous Diseases (IBD, Wegener’s
and Sarcoid) - Potential Explanations
William Rigby |
| 4:40
PM |
|
Adjourn |
| 6:00
PM |
|
Welcoming
Reception & Poster Session |
| 7:30
AM |
|
Breakfast
& Registration |
Session
III: TNF in Multiple Diseases
Moderators: Brian Mandell & Steven LaRosa |
| 8:30
AM |
|
TNF
and Granulomatous Infections
JoAnne Flynn |
| 9:10
AM |
|
TNF
and Demyelinating Diseases Jeffrey Cohen |
| 9:50
AM |
|
Refreshment
Break |
| 10:10
AM |
|
TNF
Inhibition & Malignancy: Assessing the Risks
John Cush |
| 10:50
AM |
|
TNF
Inhibitors and CHF – Is the Story Over?
James Young |
| 11:30
AM |
|
TNF
Inhibitors and Septic Shock – Is the Story Over?
Steven LaRosa |
| 12:10
PM |
|
Luncheon |
| Concurrent
Sessions |
Concurrent
Session A
Rheumatology
Moderator: William St. Clair |
| 1:10
PM |
|
When
is it Early Enough to Start a TNF Inhibitor in RA (Issues
Surrounding What Metrics We Should Be Using in Practice, Role
of MR, & Ultrasound)
William St. Clair |
| 1:40
PM |
|
Update
in Psoriatic Arthritis & Spondyloarthropathy
Christopher Ritchlin |
| 2:10
PM |
|
My
Patient Has Failed a TNF Inhibitor- Should I Switch and What
Else Can I Do? What Are the Data?
Edward Keystone |
| 2:40
PM |
|
Refreshment
Break |
| 3:10
PM |
|
Current
Status of Biologic Therapies in the Treatment of Vasculitis
Gary Hoffman |
| 3:40
PM |
|
Panel
Discussion
Gary Hoffman, Edward Keystone, Christopher Ritchlin &
William St. Clair |
| 4:00
PM |
|
Adjourn |
Concurrent
Session B
Dermatology
Moderator: Jonelle McDonnell |
| 1:10
PM |
|
General
Approach to the Patient with Complex Psoriasis
Charles Camisa |
| 1:40
PM |
|
Overview
of Biologic Agents in the Treatment of Psoriasis and Allied
Conditions
Neil Korman |
| 2:10
PM |
|
Small
Molecular Inhibitors of TNF Including Thalidomide in the Treatment
of Dermatologic Disorders
Jonelle McDonnell |
| 2:40
PM |
|
Refreshment
Break |
| 3:10
PM |
|
Psoriatic
Arthritis Clinical Assessment & Management Issues
Christopher Ritchlin |
| 3:40
PM |
|
Panel
Discussion
Charles Camisa, Neil Korman, & Jonelle McDonnell |
| 4:00
PM |
|
Adjourn |
Concurrent
Session C
Gastroenterology
Moderators: Bret Lashner & Nizar Zein |
| 1:10
PM |
|
TNF
Inhibitor Therapy in Patients with Ulcerative Colitis
Jean-Paul Achkar |
| 1:40
PM |
|
TNF
Inhibitor Therapy in Patients with Crohn’s Disease
Bret Lashner |
| 2:10
PM |
|
Role
of TNF Inhibitor Therapy in Patients with Acute & Chronic
Liver Disease
Nizar Zein |
| 2:40
PM |
|
Refreshment
Break |
| 3:10
PM |
|
A
Patient with IBD Referred for Initiation of Anti-TNF Therapy
Aaron Brzezinski |
| 3:40
PM |
|
Panel
Discussion
Jean-Paul Achkar, Aaron Brzezinski, Bret Lashner, &
Nizar Zein |
| 4:00
PM |
|
Adjourn |
| 7:30
AM |
|
Breakfast
& Registration |
Mini-Symposia
Managing the Problem Patient with Anti-TNF Inhibitor Therapy:
Infectious, Malignant, Neurologic and Other Complex Issues
Moderators: Leonard Calabrese & Nizar Zein |
| 8:10
AM |
|
Ganulomatous
Infections & TNF Inhibitors – Assessing the Risks
& Benefits
Steven Gordon & William St. Clair |
| 8:50
AM |
|
New
CNS Signs & Symptoms in a Patient on TNF Inhibitors
Jeffrey Cohen & Christopher Ritchlin |
| 9:30
AM |
|
New
Cutaneous Vasculitis in a Patient on TNF Inhibitors? Etiology
& Management
Gary Hoffman |
| 10:00
AM |
|
Refreshment
Break |
| 10:30
AM |
|
Hepatitis
Issues
Nizar Zein |
| 11:00
AM |
|
When
is Neoplasia a Cause for Concern in Patients Who Are Candidates
for TNF Inhibitors? John Cush |
| 11:30
AM |
|
Are
TNF Inhibitors a Viable Option for Sarcoidosis?
Daniel Culver |
| 12:00
PM |
|
Which
Bacterial Infections Cause a Concern in Patients on TNF Inhibitors?
Steven LaRosa |
| 12:30
PM |
|
The
Pregnant Patient on TNF Inhibitors
Edward Keystone |
| 1:00
PM |
|
Closing
Remarks & Adjournment |
